Legalize / European Union / Delegated Regulation

Commission Delegated Regulation (EU) 2020/688 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council, as regards animal health requirements for movements within the Union of terrestrial animals and hatching eggs (Text with EEA relevance) (Text with EEA relevance)

Type Delegated Regulation

Publication 2019-12-17

Last updated 2025-01-09

State In force

Department European Commission, SANTE

Source EUR-Lex

articles 108

Reform history JSON API

Operators shall only move wild terrestrial animals from their habitat of origin to a habitat or an establishment in another Member State when the following additional requirements are fulfilled:

(a) the majority of the animals of the consignment have been resident in the habitat of origin for at least 30 days prior to departure, or since birth, if they are younger than 30 days of age, and during this period they have not been in contact with kept animals of a lower health status or subject to movement restrictions for animal health reasons or with kept animals coming from an establishment which did not fulfil the requirements set out in point (b);

(b) any animals entering the Union from a third country or territory during the last 30 days prior to the departure of the animals referred to in paragraph 1, and introduced into an establishment situated in the habitat where those animals were resident, are kept separate so as to prevent direct and indirect contact with all other animals on that establishment and in the habitat;

(c) animals that are of listed species for the relevant diseases, come from a habitat in which the following diseases and infections have not been reported during the stipulated timeframes: (i) infection with rabies virus during the last 30 days prior to departure; (ii) infection with Brucella abortus, B. melitensis and B. suis in wild terrestrial animals of listed species for that disease during the last 42 days prior to departure; (iii) infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in wild terrestrial animals of listed species for that disease during the last 42 days prior to departure; (iv) infection with epizootic haemorrhagic disease virus within a radius of 150 km in wild terrestrial animals of listed species for that disease during the last 2 years prior to departure; (v) anthrax in ungulates during the last 15 days prior to departure; (vi) surra (Trypanosoma evansi) during the last 30 days prior to departure;

(d) when those animals belong to the families of Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae, Moschidae or Tragulidae, the habitat of origin shall be in compliance with at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in points 1 to 3 of Section 1 of Chapter 2 of Part II of Annex V to Delegated Regulation (EU) 2020/689;

(e) those animals are not known to have been in contact with wild terrestrial animals which did not fulfil the requirements set out in point (c) during the last 30 days prior to departure.

By way of derogation from paragraph 4(d) of this Article, the competent authority of the Member State of origin may authorise the movement of wild terrestrial animals belonging to the families of Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae, Moschidae or Tragulidae, originating in a habitat which is not in compliance with at least one of the requirements for infection with Bluetongue virus (serotype 1-24) set out in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 to another Member State or zone thereof:

(a) with a disease-free status or with an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised under the conditions referred to in Article 43(2) of Delegated Regulation (EU) 2020/689; or

(b) without a disease-free status and an approved eradication programme for infection with Bluetongue virus (serotype 1-24), if the Member State of destination has informed the Commission and the other Member States that such movements are authorised. If the Member State of destination sets conditions for the authorisation of such movement, those conditions must be any one of the conditions referred to in points 5 to 8 of Section 1 of Chapter 2 of Part II of Annex V of Delegated Regulation (EU) 2020/689.

Article 102

Details on content of animal health certificate for wild terrestrial animals

The animal health certificate for wild terrestrial animals, that is issued by the competent authority of the Member State of origin in accordance with Article 155(1)(c) of Regulation (EU) 2016/429, shall contain the general information provided for in point 3 of Annex VIII and an attestation of compliance with the requirements provided for in Article 101(4), and those in Article 101(5) of this Regulation where applicable.

Article 103

Rules concerning the responsibility of the competent authority for animal health certification for movements of wild terrestrial animals to other Member States

Before signing the animal health certificate provided for in Article 102 for the movement of wild terrestrial animals, the official veterinarian shall carry out the following types of identity check and examinations:

(a) an examination of available information demonstrating that the requirements provided for in Article 101(4) are fulfilled;

(b) an identity check;

(c) a clinical examination, and where this is not possible, a clinical inspection of the animals of the consignment for the purpose of detection of clinical signs or suspicion of listed or emerging diseases relevant for the species.

Article 104

Requirements for advance notification by operators of movements of wild terrestrial animals to other Member States

Operators other than transporters moving wild terrestrial animals to another Member State shall notify the competent authority of the Member State of origin at least 24 hours before the departure of the consignment.

Article 105

Obligation of operators concerning the notification of movements of wild terrestrial animals to other Member States

For the purposes of the notification referred to in Article 155(1)(d) of Regulation (EU) 2016/429, operators other than transporters moving wild terrestrial animals to another Member State shall provide the competent authority in the Member State of origin with the information provided for in Article 145(1) of Regulation (EU) 2016/429 and in points 3(a) to (d) in Part 1 of Annex VIII concerning each consignment of those animals to be moved to another Member State.

Article 106

Responsibility of the competent authority concerning the notification of movements of wild terrestrial animals to other Member States

The competent authority of the Member State of origin notifying the competent authority of the Member State of destination in accordance with Article 155(1)(d) of Regulation (EU) 2016/429, shall provide the information provided for in points 3(a) to (d) in Part 1 of Annex VIII concerning each consignment of wild terrestrial animals to be moved to another Member State.

Article 107

Emergency procedures

In the event of power cuts and other disturbances of IMSOC, the competent authority of place of origin of wild terrestrial animals shall comply with the contingency arrangements established pursuant to Article 134(d) of Regulation (EU) 2017/625.

PART IV

FINAL PROVISIONS

Article 108

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

It shall apply as of 21 April 2021.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

ANNEX I

DIAGNOSTIC METHODS

Part 1 Infection with Brucella abortus, B. melitensis and B. suis

1.Serological tests for bovine, ovine, caprine and camelid animals:

(a) buffered Brucella antigen tests;

(b) complement fixation test (CFT);

(d) fluorescence polarisation assay (FPA);

(e) competitive enzyme-linked immunosorbent assay (C-ELISA).

2.Serological tests for porcine animals:

(a) buffered Brucella antigen tests;

(b) complement fixation test (CFT);

(d) fluorescence polarisation assay (FPA);

(e) competitive enzyme-linked immunosorbent assay (C-ELISA).

3.Brucellin skin test (BST) for ovine, caprine and porcine animals

Part 2 **Infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis)**

1.Tuberculin skin tests:

(a) the single intradermal tuberculin test (SITT);

(b) the comparative intradermal tuberculin test (CITT).

2.Test available for blood samples:

(a) gamma-interferon assay.

Part 3 **Surra (Trypanosoma evansi)**

Serological tests:

(a) enzyme-linked immunosorbent assay (ELISA) for trypanosomiasis;

(b) card agglutination test for trypanosomiasis (CATT) at a serum dilution of 1:4.

Part 4 Enzootic bovine leukosis

Serological tests:

(a) tests for blood samples: (i) agar gel immuno-diffusion test (AGID); (ii) blocking enzyme-linked immunosorbent assay (B-ELISA); (iii) indirect enzyme-linked immunosorbent assay (I-ELISA).

(b) test for milk samples: (i) indirect enzyme-linked immunosorbent assay (I-ELISA).

Part 5 Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis

	Methods:
Non-vaccinated bovine animals	BoHV-1 I-ELISA ()
gB B-ELISA ()
Bovine animals vaccinated with a gE-deleted vaccine	gE B-ELISA ()
(¹) enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against BoHV-1 whole virus. (²) ELISA for the detection of antibodies against BoHV-1-gB protein. When referred to tests for the detection of antibodies against whole BoHV-1, this method may also be used. (³) ELISA for the detection of antibodies against BoHV-1-gE protein.

Part 6 Bovine viral diarrhoea

1.Direct methods:

(a) real-time reverse transcription-polymerase chain reaction (real-time RT-PCR);

(b) bovine viral diarrhoea virus (BVDV) antigen detection enzyme-linked immunosorbent assay (ELISA);

2.Serological tests:

(a) indirect enzyme-linked immunosorbent assay (I-ELISA);

(b) blocking enzyme-linked immunosorbent assay (B-ELISA);

Part 7 Infection with Aujeszky’s disease virus

	Methods:
Porcine animals	Aujeszky’s disease virus (ADV) ELISA ()
Porcine animals less than 4 months old born to dams vaccinated with a gE-deleted vaccine	gE ELISA ()
(¹) ELISA for the detection of antibodies against whole ADV, ADV-gB protein or ADV-gD protein. For batch control of ADV-gB kits and ADV-gD kits or whole ADV kits, Community reference serum ADV 1, or sub-standards, must be scored positive at a dilution of 1:2. (²) ELISA for the detection of antibodies against ADV-gE protein. For batch control, Community reference serum ADV 1, or sub-standards, must be scored positive at a dilution of 1:8.

Part 8 Dourine

Complement fixation test for dourine, at a serum dilution of 1:5.

Part 9 Equine infectious anaemia

Serological tests:

(a) agar gel immuno-diffusion test (AGID);

(b) enzyme-linked immunosorbent assay (ELISA) for equine infectious anaemia.

Part 10 Venezuelan equine encephalomyelitis

1.Serological tests:

(a) virus isolation test for Venezuelan equine encephalomyelitis;

(b) haemagglutination inhibition test for Venezuelan equine encephalomyelitis;

2.Direct method:

reverse transcription-polymerase chain reaction (RT-PCR) for the detection of Venezuelan equine encephalomyelitis virus genome.

ANNEX II

**MINIMUM PRE-MOVEMENT REQUIREMENTS AS REGARDS INFECTION WITH MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE AND M. TUBERCULOSIS) IN CAPRINE, CAMELID AND CERVID ANIMALS**

Part 1 **Minimum requirements for a pre-movement programme as regards infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals**

1.The pre-movement surveillance programme to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in an establishment for the purpose of movement to another Member State of kept caprine animals as referred to in Article 15(3) must at least include the following elements:

(a) post-mortem inspection of all slaughtered caprine animals from the establishment;

(b) post-mortem examination of fallen stock of all caprine animals older than 9 months, unless impossible for logistical reasons or not necessary for scientific reasons;

(d) annual testing of all caprine animals kept on the establishment for breeding purposes, with negative results.

2.By way of derogation from paragraph 1, the annual testing provided for in point 1(d) does not have to be required if the competent authority, based on a risk assessment, considers the risk of infection as negligible in the Member State or zone, and the following conditions are fulfilled:

(a) the elements referred to in points 1(a), (b) and (c), that constitute a part of the pre-movement surveillance programme established in point 1, have been carried out on the establishment referred to in point 1 for at least 24 months, and infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals kept on that establishment has not been reported during this period;

(b) the establishment is situated in a Member State or zone thereof free from infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in its bovine animal population.

3.If infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in caprine animals kept on the establishment referred to in point 1 has been reported, such animals may be moved to another Member State only when all caprine animals older than 6 weeks kept on that establishment have been tested, with negative results. These tests must be carried out on caprine animals or on samples collected from caprine animals no earlier than 42 days after the removal of the last confirmed case and of the last animal which tested positive using a diagnostic method.

Part 2 **Minimum requirements for a pre-movement programme as regards infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in camelid animals**

1.The pre-movement surveillance programme to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in an establishment for the purpose of movement to another Member State of kept camelid animals as referred to in Article 23(1)(e) must at least include the following elements:

(a) post-mortem inspection of all slaughtered camelid animals from the establishment;

(b) post-mortem examination of fallen stock of camelid animals older than 9 months, unless impossible for logistical reasons or not necessary for scientific reasons;

(d) annual testing of all camelid animals kept on the establishment for breeding purposes, with negative results.

(a) the pre-movement surveillance programme referred to in paragraph 1 has been carried out on the establishment for at least 24 months and infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in camelid animals kept on the establishment has not been reported during this period;

3.If infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in camelid animals kept on the establishment referred to in point 1 has been reported, such animals may be moved to another Member State only when all camelid animals older than 6 weeks kept on that establishment have been tested, with negative results. These tests must be carried out on camelid animals or on samples collected from camelid animals no earlier than 42 days after the removal of the last confirmed case and of the last animal which tested positive using a diagnostic method.

Part 3 **Minimum requirements for a pre-movement programme as regards infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in cervid animals**

1.The pre-movement surveillance programme to detect infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in an establishment for the purpose of movement to another Member State of kept cervid animals as referred to in Article 26(1)(e) must at least include the following elements:

(a) post-mortem inspection of all slaughtered cervid animals from the establishment;

(b) post-mortem examination of fallen stock of cervid animals older than 9 months, unless impossible for logistical reasons or not necessary for scientific reasons;

(d) annual testing of cervid animals kept on the establishment for breeding purposes, with negative results.

(a) the pre-movement surveillance programme referred to in paragraph 1 has been carried out on the establishment for at least 24 months, and infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in cervid animals kept on the establishment has not been reported during this period;

3.If infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) in cervid animals kept on the establishment has been reported, such animals may be moved to another Member State only when all cervid animals older than 6 weeks kept on the establishment have been tested on two occasions, with a minimum interval of 6 months, for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis), with negative results. The first test must be performed on cervid animals or samples collected from cervid animals no earlier than 6 months after the removal of the last confirmed case and of the last animal which tested positive using a diagnostic method.

ANNEX III

**MINIMUM PRE-MOVEMENT REQUIREMENTS AS REGARDS INFECTION WITH BRUCELLA ABORTUS, B. MELITENSIS AND B SUIS IN PORCINE ANIMALS**

1.The pre-movement surveillance programme to detect infection with Brucella abortus, B. melitensis and B suis in an establishment for the purpose of movement to another Member State of kept porcine animals, as referred to in Article 19(1)(f)(ii), must at least include the following elements:

(a) an annual animal health visit carried out by a veterinarian;

(b) if porcine animals are kept on the establishment for breeding, an annual immunological survey carried out in the porcine population of that establishment, using one of the diagnostic methods listed in Part 1(2) of Annex I, with at least a capacity to demonstrate with a 95 % level of confidence the absence of infection with Brucella abortus, B. melitensis and B. suis with a target prevalence of 10 %.

2.By way of derogation from point 1, the animal health visit referred to in point 1(a) and the survey provided for in point 1(b) does not have to be required if the competent authority, based on a risk assessment, considers the risk of infection with Brucella abortus, B. melitensis and B. suis as negligible in the Member State or zone thereof, and the following conditions are fulfilled:

(a) infection with Brucella abortus, B. melitensis and B. suis has not been reported in the kept porcine population for the last five years;

(b) infection with Brucella abortus, B. melitensis and B. suis has not been reported in the population of wild animals of listed species for the past 5 years, and during that period of time, wild boars have been included in the targeted animal population for surveillance as provided for in Article 4 of Delegated Regulation (EU) 2020/689;

(c) the Member State or zone thereof is free from infection with Brucella abortus, B. melitensis and B. suis in its bovine, ovine and caprine populations.

3.If infection with Brucella abortus, B. melitensis and B. suis in porcine animals kept on the establishment has been reported, such animals may be moved to another Member State only when all porcine animals kept on the establishment have been subjected to a test on two occasions, with negative results. The first test must be carried out on samples collected no earlier than 3 months after the removal of the infected animals and the animals which tested positive using one of the diagnostic methods provided for in Part 1(2) of Annex I. The second test must be carried out on samples collected no earlier than 6 months and no later than 12 months after the first test.

ANNEX IV

TESTING OF DUCKS AND GEESE FOR HIGHLY PATHOGENIC AVIAN INFLUENZA

During the week prior to the time of loading for dispatch, ducks and geese must have tested negative in a virological examination for highly pathogenic avian influenza, either by virus isolation or by molecular testing at a level which gives 95 % confidence of detecting infection at 5 % prevalence.

ANNEX V

REQUIREMENTS FOR TESTING CONSIGNMENTS OF LESS THAN 20 HEADS OF POULTRY OTHER THAN RATITES OR LESS THAN 20 HATCHING EGGS OF POULTRY OTHER THAN RATITES

1.Consignments of less than 20 heads of poultry other than ratites or less than 20 hatching eggs of poultry other than ratites must have tested negative in accordance with point 2 for the following disease agents for the relevant listed species:

(a) infection with Salmonella Pullorum, S. Gallinarum and S. arizonae;

(b) avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis).

2.Testing:

(a) for breeding poultry, productive poultry and poultry intended for slaughter, the animals must have tested negative in serological and/or bacteriological tests for the diseases under point 1 within 21 days preceding the time of loading for dispatch;

(b) for hatching eggs and day-old chicks, the flock of origin must have tested negative in serological tests and/or bacteriological tests for the diseases under point 1 within 21 days preceding the time of loading for dispatch at a level which gives 95 % confidence of detecting infection at 5 % prevalence;

(c) if the animals have been vaccinated against infection with any serotype of Salmonella or Mycoplasma, only bacteriological testing must be used. The confirmation method must be capable of differentiating between live vaccinal strains and field strains.

ANNEX VI

CRITERIA FOR VACCINES AGAINST INFECTION WITH NEWCASTLE DISEASE VIRUS

Live attenuated vaccines against infection with Newcastle disease virus must be prepared from a Newcastle disease virus strain for which the master seed has been tested and shown to have an intracerebral pathogenicity index (ICPI) of:

(a) less than 0,4 if not less than 10⁷ EID50 (50 % Embryo Infectious Dose) are administrated to each bird in the ICPI test; or

(b) less than 0,5 if not less than 10⁸ EID50 are administered to each bird in the ICPI test.

ANNEX VII

VALIDITY OF ANTI-RABIES VACCINATION AND RISK-MITIGATING MEASURES FOR DISEASES OTHER THAN RABIES

Part 1 Validity of anti-rabies vaccinations for dogs, cats, ferrets and other carnivores

The validity requirements for vaccination against infection with rabies virus referred to in Articles 53(b)(i), 55(b)(i) and 58(1)(c) are those set out in Annex III to Regulation (EU) No 576/2013 of the European Parliament and of the Council (³).

Where no anti-rabies vaccine is authorised in a Member State for carnivores other than dogs, cats and ferrets, anti-rabies vaccination carried out in accordance with Article 10(1) of Directive 2001/82/EC must be deemed valid.

Part 2 Risk-mitigating measures for diseases other than rabies

1.The risk-mitigating measures for infestation with Echinococcus multilocularis referred to in Articles 53(b)(ii) and 55(b)(ii) are those laid down in Commission Delegated Regulation (EU) 2018/772 (⁴) in combination with Commission Implementing Regulation (EU) 2018/878 (⁵).

2.By way of derogation from paragraph 1, the treatment referred to in Article 58(1)(d) of canidae other than dogs against infestation with Echinococcus multilocularis must be carried out and documented no earlier than 48 hours prior to entry into a Member State or zone thereof listed in the Annex to Implementing Regulation (EU) 2018/878.

3.The risk-mitigating measures for diseases other than infection with rabies virus and infestation with Echinococcus multilocularis referred to in Articles 53(b)(ii) and 55(b)(ii) are the preventive health measures applicable to the relevant species of carnivores adopted in accordance with Article 19(1) of Regulation (EU) No 576/2013.

ANNEX VIII

INFORMATION TO BE CONTAINED IN ANIMAL HEALTH CERTIFICATES AND NOTIFICATIONS

Part 1 Information to be contained in the animal health certificate for terrestrial animals and hatching eggs moved to another Member State

1.The animal health certificate for the kept terrestrial animals referred to in Article 143(1) of Regulation (EU) 2016/429 and in Article 71(1) of this Regulation moved to another Member State must contain at least the following information:

(a) the name and address of the consignor and the consignee;

(b) the name and address of the establishment of dispatch, and (i) where the establishment of dispatch is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of dispatch is a registered establishment, the unique registration number of that establishment;

(c) the name and address of the establishment of destination, and (i) where the establishment of destination is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of destination a registered establishment, the unique registration number of that establishment;

(d) the species and category of animals and identification, where required;

(e) information on the animal health situation and additional guarantees in relation to: (i) the Member State or zone of origin; (ii) the establishment and flock of origin of the animals, including test results where applicable; (iii) the animals to be dispatched, including test results or vaccinations where applicable;

(f) the date and place of issue and period of validity of the animal health certificate, the name, capacity and signature of the official veterinarian, and the stamp of the competent authority of the place of origin of the consignment.

2.The animal health certificate for hatching eggs referred to in Article 161(1) of Regulation (EU) 2016/429 and in Article 72 of this Regulation moved to another Member State must contain at least the following information:

(a) the name and address of the consignor and the consignee;

(c) the name and address of the establishment of destination, and, (i) where the establishment of destination is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of destination a registered establishment, the unique registration number of that establishment;

(d) the category of hatching eggs;

(e) information allowing identification of hatching eggs: (i) the species and identification, where required, of the animals from which they originate; (ii) the marking applied on the hatching eggs, where required; (iii) the place and date of their collection;

(f) information on the animal health situation and additional guarantees in relation to: (i) the Member State or zone thereof of origin; (ii) the establishment and flock of origin, including test results where applicable; (iii) the animals from which hatching eggs were collected, including test results where applicable; (iv) the hatching eggs to be dispatched;

(g) the date and place of issue and the period of validity of the animal health certificate and the name, capacity and signature of the official veterinarian, and the stamp of the competent authority of the place of origin of the consignment.

3.The animal health certificate for wild terrestrial animals referred to in Article 155(1)(c) of Regulation (EU) 2016/429 moved to another Member State must contain at least the following information:

(a) the name and address of the consignor and the consignee;

(b) the place where animals were captured and loaded for dispatch;

(c) the place of destination, and (i) where the place of destination is the habitat, the place where animals are intended to be unloaded; or (ii) where the establishment of destination is a registered establishment, the unique registration number of that establishment;

(d) the species and category of animals;

(e) the date and place of issue and period of validity of the animal health certificate, the name, capacity and signature of the official veterinarian, and the stamp of the competent authority of the place of origin of the consignment.

Part 2 Information in the notification of movements for certain terrestrial animals for which animal health certificate is not required

The notification for moving bumble bees from approved environmentally isolated production establishments to another Member State must contain at least the following information:

(a) the name and address of the consignor and the consignee;

(b) the name, address and unique approval number of the establishment of dispatch;

(c) the name and address of the establishment of destination, and (i) where the establishment of destination is an approved establishment, the unique approval number of that establishment; or (ii) where the establishment of destination is a registered establishment, the unique registration number of that establishment;

(d) the species, category and quantity and size of colonies;

(e) the date of dispatch.

ANNEX IX

Part 1 Zones seasonally-free from epizootic hemorrhagic disease

1.In the event of movements to other Member States of kept ungulates, zones seasonally-free from epizootic haemorrhagic disease may be established if the beginning and the end of the vector-free period has been demonstrated by the competent authority based on entomological surveillance in accordance with Part 2.

2.By way of derogation from point 1, if the vector-free period has been successfully demonstrated for a period of 3 consecutive years, additional criteria such as temperature may replace entomological surveillance to substantiate the beginning and the end of the vector-free period on the basis of scientific evidence.

3.The zones seasonally-free from epizootic haemorrhagic disease shall immediately be eliminated when there is evidence of the end of the vector-free period or of circulation of the epizootic haemorrhagic disease virus.

Part 2 Entomological surveillance

1.Entomological surveillance shall consist of at least an active annual programme of vector catching by means of permanently sited aspiration traps intended to determine the population dynamics of the vector and, where relevant, the vector-free period.

2.Aspiration traps equipped with ultraviolet light shall be used in accordance with pre-established protocols; the traps shall be operated throughout the night and operate at least:

(a) one night per week during the month before the expected beginning and during the month before the expected end of the vector-free period; and

(b) one night per month during the vector-free period.

On the basis of the evidence obtained in the first 3 years of operating the aspiration traps, the frequency of operation of those traps may be adjusted.

3.At least one aspiration trap must be placed in each geographical unit of 45 km by 45 km throughout the zone seasonally-free from epizootic haemorrhagic disease and the geographical units can be adapted to the epidemiological situation. A proportion of the midges collected in the aspiration traps shall be sent to a specialised laboratory capable of counting and identifying the suspected vector species or complexes.

4.When entomological surveillance is organised in the context of determination of a vector-free period, a maximum threshold of Culicoides species shall be defined for the interpretation of the results. In the absence of sound evidence supporting the determination of the maximum threshold, total absence of Culicoides imicola specimens and less than five parous Culicoides per trap shall be used as maximum threshold..

Part 3 Vector protected establishment

Vector protected establishment shall comply with the following requirements:

(a) it has appropriate physical barriers at entry and exit points;

(b) openings shall be vector screened with mesh of appropriate gauge which shall be impregnated regularly with an approved insecticide according to the manufacturers’ instructions;

(d) measures shall be taken to limit or eliminate breeding sites for vectors in the vicinity of the vector protected establishment; and

(e) standard operating procedures shall be in place, including descriptions of back-up and alarm systems, for operation of the vector protected establishment and transport of animals to the place of loading.

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.